Skip to content

Osteogenesis Imperfecta Type 7 C1853162

Published: July 22, 2026Updated: August 25, 2026

A severe OI type caused by CRTAP gene mutations, leading to profound bone fragility and growth deficiency. Managed with orthopedic interventions and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Long bone fractures

(musculoskeletal)

Progressive femoral deformity

(musculoskeletal)

Growth deficiency

(musculoskeletal)

Rhizomelic limb shortening

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Bisphosphonate Treatment

Bisphosphonate therapy is a cornerstone of OI type 7 management, administered to reduce bone pain, increase bone mineral density, and decrease fracture frequency through inhibition of osteoclast activity.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Rehabilitation Therapy Program

Individualized therapy focusing on safe mobility, strength training within limits of bone fragility, and functional independence. Therapists teach proper handling techniques to prevent fractures during daily activities.

physical_therapy

Additional treatment options

Scoliosis Management

When scoliosis progresses beyond 40-50 degrees or causes respiratory compromise, surgical correction with spinal instrumentation may be necessary. This requires careful pre-operative planning due to bone fragility.

surgical

Pain Management Support

Multimodal approach to chronic bone pain including physical modalities, positioning aids, and appropriate analgesic medications. Non-pharmacological techniques such as cognitive behavioral therapy may complement medical management.

complementary

Multidisciplinary Surveillance

Regular follow-up with bone specialists, geneticists, pulmonologists, and audiologists monitors disease progression and complication development. Annual DEXA scans assess bone density changes.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Osteogenesis Imperfecta Type 7 C1853162?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Balkany TJ, Marcellus DF. National consensus guidelines for osteogenesis imperfecta management. Orphanet J Rare Dis. 2019.

guideline2019
2

Van Dijk FS, Pajor JM, Nikkels PG. Osteogenesis imperfecta: a review of clinical subtypes and molecular mechanisms. Mol Genet Genomic Med. 2020.

review2020
3

Rauch F, Lalic L, Glorieux FH. Bisphosphonate therapy in osteogenesis imperfecta type VII: a prospective trial. Bone. 2017.

clinical_trial2017
4

Liu Y, Arkin JE, Lee JL. Treatment outcomes in severe OI: systematic review and meta-analysis. J Clin Endocrinol Metab. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Osteogenesis Imperfecta Type 7 C1853162. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy